Inanovate Inc.

Inanovate Inc. is a clinical laboratory diagnostics company headquartered in Sioux Falls, South Dakota, with additional operations in Raleigh, North Carolina. The company develops and commercializes the Bio-ID, a proprietary bench-top protein screening analyzer platform designed to detect and measure multiple disease-related biological molecules (biomarkers) from patient blood samples. The Bio-ID platform integrates Inanovate's proprietary Longitudinal Assay Screening (LAS) technology, developed since 2010, which enables accurate detection and measurement of complex protein signatures at virtually any concentration without requiring multiple sample dilutions or complex sample preparation. The Bio-ID consists of a compact analyzer and disposable test cartridges; end users load samples into cartridges, insert them into the analyzer, and the system automatically performs analysis. The technology is positioned to reduce diagnostic testing costs while improving accuracy and serves both research and clinical markets. Inanovate's mission focuses on enabling access to the diagnostic power of the proteome through multiplexed serological analysis. The company offers the Bio-ID 800 analyzer, disposable test cartridges, an alliance program for research partners, and associated services. Products enable next-generation diagnostic and therapeutic development across various disease applications. The company has completed technology validation and benchmarking of its core platform.